Circulating IGF-I: New Perspectives for a New Century

Area of Science:

• Endocrinology
• Genetics
• Cancer Research

Background:

• Insulin-like Growth Factor I (IGF-I) is a key regulator of cell proliferation and differentiation.
• IGF-I is linked to Growth Hormone (GH) and has implications for chronic diseases and aging.
• Epidemiological data suggest a link between high-normal IGF-I levels and increased cancer risk.

Purpose of the Study:

• To review recent data on the determinants of serum IGF-I levels.
• To explore the role of heritable factors in regulating IGF-I.
• To reassess the physiological significance of IGF-I level heterogeneity.

Main Methods:

• Review of recent scientific literature and epidemiological evidence.
• Analysis of genetic and non-genetic factors influencing IGF-I.
• Examination of IGF-I's role in bone remodeling, atherosclerosis, and neoplasia.

Main Results:

• Adult serum IGF-I levels are influenced by heritable factors independent of GH.
• These factors may affect IGF-I tissue expression and serum levels.
• IGF-I levels may serve as a surrogate marker for factors involved in carcinogenesis.

Conclusions:

• Individual variations in IGF-I levels within the normal range may have significant physiological implications.
• Heritable factors controlling IGF-I influence bone density and cancer risk.
• The established view of IGF-I's physiological importance requires re-evaluation.